Component
Rat L6 myotube glucose consumption
Rat L6 myotube glucose consumption. Species, exposure and limitations are retained in each linked claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
In insulin-resistant L6 cells, mangiferin increased glucose consumption only with insulin co-treatment; norathyriol worked with or without insulin.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/mangiferin-research/24033319.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9e8f13eba529ca6e56c33c3cee21d8fef473025e4bea72d81b375c96031ee84a", "start_char": 0, "end_char": 1791, "text_sha256": "9e8f13eba529ca6e56c33c3cee21d8fef473025e4bea72d81b375c96031ee84a"}
- experimental_model
- Normal and insulin-resistant L6 myotube comparison
- exposure
- Micromolar mangiferin or norathyriol, with or without 0.05 nM insulin
- limitations
- Cell glucose consumption and phosphorylation assays; AMPK association alone does not prove direct binding or human glucose lowering.
- nutrient_topic
- Mangiferin research collection; topical membership is not evidence of a direct dietary effect. · Mangiferin
- organism
- Rattus norvegicus
- plain_language
- The parent compound and metabolite differed under insulin resistance.
- primary_references
- [mangiferin-p24033319] Mangiferin and its aglycone, norathyriol, improve glucose metabolism by activation of AMP-activated protein kinase. (2014). https://pubmed.ncbi.nlm.nih.gov/24033319/ DOI: 10.3109/13880209.2013.814691
- tissue_or_cell_type
- L6 myotubes
Mangiferin: metabolism, signaling and nutrient connections (2026-09-17) · lines 418–429
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Normal and insulin-resistant L6 myotube comparison · source_derived_draft · unverified_draft
### mangiferin-insulin-context In insulin-resistant L6 cells, mangiferin increased glucose consumption only with insulin co-treatment; norathyriol worked with or without insulin. Condition category: normal nutrient_topic: Mangiferin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The parent compound and metabolite differed under insulin resistance. organism: Rattus norvegicus tissue_or_cell_type: L6 myotubes experimental_model: Normal and insulin-resistant L6 myotube comparison limitations: Cell glucose consumption and phosphorylation assays; AMPK association alone does not prove direct binding or human glucose lowering. exposure: Micromolar mangiferin or norathyriol, with or without 0.05 nM insulin evidence_span: {"source_cache": "artifacts/mangiferin-research/24033319.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9e8f13eba529ca6e56c33c3cee21d8fef473025e4bea72d81b375c96031ee84a", "start_char": 0, "end_char": 1791, "text_sha256": "9e8f13eba529ca6e56c33c3cee21d8fef473025e4bea72d81b375c96031ee84a"} [mangiferin-p24033319] Mangiferin and its aglycone, norathyriol, improve glucose metabolism by activation of AMP-activated protein kinase. (2014). https://pubmed.ncbi.nlm.nih.gov/24033319/ DOI: 10.3109/13880209.2013.814691
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.